get 73
Small moleculeexperimental
Clinical trial activity
3 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2014 (NCT01842503)
Timeline
Indications
Studied for
Mechanism of action
- Metabotropic glutamate receptor 5MODULATOR
GRM5 modulator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- get 73
- get 73
- get-73
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04831684 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2022 | Medical University of South Carolina, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH) |
| NCT03418623 | Phase 2 | Mar 8, 2018 | Laboratorio Farmaceutico Ct S.r.l., Latis Srl, Medical University of South Carolina |
| NCT01842503 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2014 | Boston University, Laboratorio Farmaceutico Ct S.r.l., Latis Srl, Quotient, Voisin Consulting, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Laboratorio Farmaceutico Ct S.r.l. | For profit | 2 | 2 | 1 | 2014 |
| Latis Srl | For profit | 2 | 0 | 1 | 2014 |
| Medical University of South Carolina | Academic/Hospital | 2 | 1 | 1 | 2018 |
| Boston University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Government | 1 | 0 | 1 | 2022 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2022 |
| Quotient | For profit | 1 | 0 | 1 | 2014 |
| Voisin Consulting, Inc. | For profit | 1 | 0 | 1 | 2014 |
8 organizations
Page 1 / 1